Results 111 to 120 of about 3,683 (169)

Cardiac manifestations of Fabry disease. [PDF]

NPJ Cardiovasc Health
Dougherty S, Germain DP, Oudit GY, Li A, Leung SP, Zhao CX, Lee A.   +6 more
europepmc   +1 more source

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype. [PDF]

Cells
Lattanzio A, Marchionni G, Pecci G, Ciccarelli F, Stavagna S, Costantino J, Ballatore F, Alfarano M, Ciciarello F, Chimenti C.   +9 more
europepmc   +1 more source

Lyso-Gb3 in a Fabry pediatric cohort diagnosed by newborn screening. [PDF]

Genet Med Open
Burlina AP, Gragnaniello V, Edini C, Salviati L, Polo G, Porcù E, Meloni N, Cazzorla C, Germain DP, Burlina AB.   +9 more
europepmc   +1 more source

Eliglustat prevents acute kidney injury caused by Shiga toxin 2 in lethal and sublethal rat models of hemolytic uremic syndrome. [PDF]

Front Pharmacol
Sánchez DS, Fischer Sigel LK, Zotta E, Silberstein C.   +3 more
europepmc   +1 more source

Glycosphingolipids and their impact on platelet activity in a murine model of fabry disease. [PDF]

Sci Rep
Kanack AJ, Prodoehl E, Ishihara-Aoki M, Aoki K, Dahms NM.   +4 more
europepmc   +1 more source

Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension. [PDF]

Nat Commun
Nordbeck P, Goker-Alpan O, Bernat JA, Germain DP, Giraldo P, Jovanovic A, Kimonis V, Nicholls K, Rockman-Greenberg C, Schiffmann R, Thomas M, Tylki-Szymanska A, Wallace E, Welford RWD, West ML, Clozel M, Frey A, Trokan L, Mueller MS, Vogler M, Wanner C, Hughes D.   +21 more
europepmc   +1 more source

Successful Management of Pregnancy in a Patient With Fabry Disease Receiving Continuous Enzyme Replacement Therapy: A Case Report and Literature Review. [PDF]

Cureus
Kido Y, Nakahara M, Takahashi K, Nagasawa S, Maruyama Y, Ogishima D.   +5 more
europepmc   +1 more source

Case Report: Fabry disease presenting with electrocardiographic findings mimicking acute myocardial infarction: a diagnostic challenge. [PDF]

Front Cardiovasc Med
Xie JM, Li Q, Xiao ZQ, Zheng ZJ.
europepmc   +1 more source

Chest Discomfort, Left Ventricular Hypertrophy, Global T-Wave Inversion, and Short PR Interval Points to a Particular Cardiac Condition. What Could Be the Diagnosis? [PDF]

Ann Noninvasive Electrocardiol
Li JX, Di XX, Gao M, Li XQ, Wang YL, Zheng J.   +5 more
europepmc   +1 more source

Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction. [PDF]

Mol Genet Metab Rep
Inagaki N, Takei Y, Hatano T, Takada Y, Yazaki Y, Kosuge H, Kobayashi M, Suzuki S, Umezu T, Kuroda M, Satomi K, Hayashi T.   +11 more
europepmc   +1 more source